- Anthropic’s life science plans; Novartis CEO on China deals; and moreWelcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 results. In the meant…Endpoints · 12h ago↗ source
- Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak“Consumers should not be faced with a trade-off between nutrition and food safety,” writes Susan Mayne, former director of the FDA Center for Food Safety and Applied Nutrition.STAT · 1d ago↗ source
- FDA advisory panel narrowly rejects compounding of one peptide, backs two othersRobert F. Kennedy Jr. has lauded peptides and said he takes them himself.